Does TRALOKINUMAB-LDRM Cause Injection site erythema? 136 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Injection site erythema have been filed in association with TRALOKINUMAB-LDRM. This represents 3.3% of all adverse event reports for TRALOKINUMAB-LDRM.
136
Reports of Injection site erythema with TRALOKINUMAB-LDRM
3.3%
of all TRALOKINUMAB-LDRM reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site erythema From TRALOKINUMAB-LDRM?
Of the 136 reports, 1 (0.7%) required hospitalization.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRALOKINUMAB-LDRM. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does TRALOKINUMAB-LDRM Cause?
Dermatitis atopic (613)
Drug ineffective (461)
Pruritus (365)
Rash (266)
Injection site pain (206)
Dry skin (135)
Erythema (133)
Eczema (129)
Injection site pruritus (124)
Injection site swelling (119)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which TRALOKINUMAB-LDRM Alternatives Have Lower Injection site erythema Risk?
TRALOKINUMAB-LDRM vs TRAMADOL
TRALOKINUMAB-LDRM vs TRAMADOL\TRAMADOL
TRALOKINUMAB-LDRM vs TRAMETINIB
TRALOKINUMAB-LDRM vs TRAMETINIB DIMETHYL SULFOXIDE
TRALOKINUMAB-LDRM vs TRANDOLAPRIL